Materialise NV, founded in 1990 and headquartered in Leuven, Belgium, is a global pioneer in additive manufacturing software and 3D printing services. The company operates through three primary business segments: Materialise Medical, Materialise Manufacturing, and Materialise Software. The Materialise Medical segment is the company's largest revenue driver, accounting for approximately 43.6% of total revenue in 2024. This division provides medical image processing software (Mimics), patient-specific surgical guides, and 3D-printed medical implants, benefiting from FDA-cleared and CE-marked solutions. The Materialise Manufacturing segment (approximately 39.9% of 2024 revenue) operates one of the world's largest 3D printing facilities, delivering rapid prototyping and additive manufacturing services to industrial clients in the aerospace, automotive, and consumer goods sectors. The Materialise Software segment (approximately 16.5% of 2024 revenue) develops and licenses industry-standard software, such as Magics, which enables data preparation and workflow management for 3D printers. Geographically, Materialise serves a diverse global client base across the Americas, Europe, Africa, and the Asia-Pacific region. The company's competitive moat lies in its open software architecture, which integrates seamlessly with a wide variety of 3D printing hardware, and its deep expertise in highly regulated medical applications. By combining proprietary software development with in-house manufacturing capabilities, Materialise positions itself as a critical enabler of the broader 3D printing ecosystem.
